The Food and Drug Administration on Tuesday approved Novo Nordisk's Ozempic to treat chronic kidney disease in patients who also have Type 2 diabetes, expanding the use of the wildly popular ...

The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for ...

Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic ... of worsening kidney disease or kidney failure in adults with type 2 diabetes and chronic kidney disease ...

and Novo Nordisk can now claim to have the first medication in this class approved for chronic kidney disease. The FDA has expanded the label of Ozempic, approving the Novo Nordisk product for ...

March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease ... Novo Nordisk manufactures FDA-approved semaglutide medicines, like Ozempic®.

New York, USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Novo Nordisk’s OZEMPIC Approval Heat Up the Chronic Kidney Disease Therapeutic Market | DelveInsight The FDA’s recent approval of OZEMPIC ...

This label update allows Novo Nordisk to include information about reducing the risk of chronic kidney disease (CKD) events in adults with type 2 diabetes on Ozempic's label. The label expansion ...

The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, ...

The FDA's decision means Ozempic can now be used to ... 37 million American adults are living with chronic kidney disease, according to Novo Nordisk. Get top local stories delivered to you every ...